Novocure to present at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PST on Wednesday, January 14, 2026 Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and ...
* United States based net sales decreased by 3% for full year 2025, excluding the impact of the discontinued Dunhill license. The average dollar/euro exchange rate for the 2025 fourth quarter was 1.16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results